Jim Simons’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT
Jim Simons's PPH Position: Q1 2026 in Review
Jim Simons sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2026, closing a stake of 9,300 shares — an estimated $959K sold.
Jim Simons first reported a position in PPH in Q4 2018 and held it in 12 quarters. The position peaked at $2.37M in Q2 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.
- Jim Simons reported no remaining VanEck Pharmaceutical ETF position as of Q1 2026 after selling out during the quarter.
- Jim Simons sold 9,300 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $959K.
- Jim Simons first reported a position in VanEck Pharmaceutical ETF in Q4 2018 and held it in 12 quarters.
- Jim Simons's VanEck Pharmaceutical ETF position peaked at $2.37M in Q2 2024.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.